Shareholders of Intuitive Surgical (NASDAQ:ISRG) had a rough week, with a weak first quarter preliminary results release driving shares lower. The numbers themselves were pretty ugly: A 24% decline in overall revenue, driven largely by a 59% decline in da Vinci surgical system sales.

Intuitive Surgical's management blamed hospital capital expenditure changes driven by the Affordable Care Act (also known as Obamacare) and lower procedure volumes, but even so, these were disappointing numbers for a stock that has more than tripled in the past five years.

The big question now is whether the long-term outlook for the company remains unchanged. In this video from Friday's Market Checkup, Motley Fool health care analysts David Williamson and Michael Douglass sift through the numbers and consider the major factors affecting Intuitive Surgical's performance moving forward.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology  behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and it's ability to make life-changing medical solutions never thought possible.  To learn how you can invest in this unbelievable new technology, click here now to see our free report.

David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.